Trial Profile
A Trial of Single Autologous Transplant With or Without Consolidation Therapy Versus Tandem Autologous Transplant With Lenalidomide Maintenance for Patients With Multiple Myeloma (BMT CTN 0702)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Aug 2023
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone (Primary) ; Lenalidomide (Primary) ; Melphalan
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms StaMINA Study
- 08 Jun 2021 Results (n=575) of MASS-FIX versus standard methods to predict for progression free survival (PFS) and overall survival (OS) in patients with multiple myeloma from STAMINA trial, presented at the 57th Annual Meeting of the American Society of Clinical Oncology.
- 17 Jan 2019 Results published in the Journal of Clinical Oncology
- 09 Aug 2018 Status changed from active, no longer recruiting to completed.